The Utility of Thiopurine Methyltransferase Enzyme Testing in Inflammatory Bowel Disease
OBJECTIVE: To assess the levels of red blood cell thiopurine methyltransferase (TPMT) in subjects with inflammatory bowel disease (IBD) and to determine how these levels impacted thiopurine dosing and leukopenia over the first six months of therapy.
Saved in:
Main Authors: | Laura Chisick, Curtis Oleschuk, Charles N Bernstein |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | Canadian Journal of Gastroenterology |
Online Access: | http://dx.doi.org/10.1155/2013/280860 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Usefulness of Measuring Thiopurine Metabolites in Children with Inflammatory Bowel Disease and Autoimmunological Hepatitis, Treated with Azathioprine
by: Katarzyna Bąk-Drabik, et al.
Published: (2021-01-01) -
Update of Immunomodulatory Therapy for Inflammatory Bowel Disease
by: Charles N Bernstein
Published: (1994-01-01) -
Immunosuppressive and Immunomodulatory Therapy for Inflammatory Bowel Disease
by: Charles N Bernstein, et al.
Published: (1993-01-01) -
The Utility of Fecal Calprotectin in the Real-World Clinical Care of Patients with Inflammatory Bowel Disease
by: Esmail Abej, et al.
Published: (2016-01-01) -
Personalization of thiopurine therapy: Current recommendations and future perspectives
by: Urbančič Dunja, et al.
Published: (2024-09-01)